The pace of clinical trial starts is leveling out, dropping below pre-pandemic highs with a 15% decline in 2023 compared to the year before. A third (32%) of the overall clinical trial slowdown is due to a drop in COVID-19 activity, according to a new report from the IQVIA Institute for Human Data Science. Trial starts dropped 22% from peak pandemic-related trial activity in 2021, according to the “Global Trends in R&D 2024: Activity, Productivity, and Enablers” report. The analysis counted both planned and actual trial starts for 2023.
Read the full article: Clinical Trial Launches Level Out after Pandemic Highs, Dropping 15% YoY //
Source: https://www.fiercebiotech.com/cro/clinical-trial-launches-level-out-after-pandemic-highs-dropping-15-yoy